| 证券代码 | ACCP.O |
| 证券名称 | Accelerated Pharma Inc |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | 主板 |
| 发行方式 | 公开发售 |
| 首发上市日 | - |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | Maxim Group, LLC,Rodman & Renshaw a unit of H.C. Wainwright & Co |
| 货币单位 | - |
| 公司名称 | Accelerated Pharma, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 36 Church Lane, Westport, Connecticut, USA |
| 成立日期 | 2014-05-12 |
| 董事会主席 | Daniel Perez |
| 公司属地 | United States 美国 |
| 公司网址 | www.apipharmaceuticals.com |
| 电话 | +1 (203) 520-3840 |
| 传真 | - |
| 公司简介 | Accelerated Pharma, Inc. is a clinical stage biopharmaceutical company focused on utilizing its genomic technology to (i) enhance the development of pre-existing pharmaceutical products for the treatment of various cancer indications, (ii) prospectively identify patients that may respond to such pharmaceutical products and (iii) commercialize such pharmaceutical products for sale in various markets. |